Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis
Sign Up to like & getrecommendations! Published in 2017 at "Hemodialysis International"
DOI: 10.1111/hdi.12487
Abstract: Introduction: Oral phosphate binders are the main stay of treatment of hyperphosphatemia. Adherence rates to ferric citrate, a recently approved phosphate binder, are unknown. read more here.
Keywords: citrate compared; rates ferric; ferric citrate; adherence rates ... See more keywords